आईएसएसएन: 2329-8901
Ana Maria Cuentas, John Deaton, Sonaina Khan, John Davidson and Courtney Ardita
Objective: Bacillus subtilis probiotics have been shown to influence several aspects of the human gut including motility, epithelial strength, inflammation, etc. that may change bowel movement frequency and/or type. To explore the efficacy of Bacillus subtilis (B. subtilis) DE111 in this regard, 50 people were evaluated by their stool profile, food diary and questionnaire while taking a probiotic or placebo daily over the course of 105-days.
Method: The stools were scored based on the Bristol Stool Chart index and safety was assessed using blood markers during the 0, 45 and 105 days.
Results: Statistically significant results showed those in the DE111 group moved to a healthier bowel index while those in the Placebo group stayed the same.
Conclusion: The study provided evidence that DE111 may improve occasional constipation and/or diarrhea in healthy individuals.